Forest fire alert: Scot Youngblood attacks the jab narrative leaves it in shreds

3 years ago
131

At the 2 November 2021 San Diego Board of Supervisors meeting MD Scot A Youngblood presented a tightly-scripted and well-produced attack on the jab narrative. He keyed on the Randomized Control Trial (RCT) that Pfizer needed to submit to the Food and Drug Administration (FDA) for the Emergency Use Authorization (EUA) that was eventually conceded in December of 2020 to the BioNTech BNT162b2 gene therapy product.

Youngblood explains the theory of a RCT from 0:00-0:33. Next he presents the efficacy data obtained by Pfizer for the 44,000 volunteers from 0:33-0:57. This is where it gets interesting. The RCT split the group into 22,000 who get the placebo and 22,000 who are jabbed with the gene therapy. From 0:57-1:19 he raises the issue of adverse events. First he notices that no attention has been paid until now (November 2021) to this aspect of the RCT. He shows that the jabbed half showed a statistically significant increase of double the rate of severe adverse events which by definition require hospitalization for problems such as heart attacks, strokes, myocarditis, pericarditis, Guillain-Barre syndrome, etc.

Then he presents the all-causes mortality or fatality statistics for the Pfizer-BioNTech-BT162b2 RCT from 1:19-1:55. The all-causes mortality figure are the same: 0.07% died. The RCT was un-blinded after six months and the placebo half was allowed to opt to get the jab; five more jabbed volunteers died. Thus, one cannot say that this jab reduces mortality.

Youngblood goes on to question the narrative in the segment from 1:55-2:42. One answer to this puzzle is that the risks of this gene therapy product (measured in the jabbed half of the RCT) essentially cancel out the risks of the virus (in the placebo half). Indeed the Taiwan Department of Health counted the deaths over a 7-month period in 2021 and they record that the post-jab mortality exceeds the unjabbed mortality.

From 2:42-3:00 Youngblood points out that the spike protein is a toxin. The spike protein binds to the ACE2 receptor, and the ACE2 receptor has important functions to regulate blood pressure and clotting and immune response, amongst others.

Then Youngblood questions the regulatory environment in which these gene therapy products are controlled from 3:00-4:06. Why were the requirements to present RCT studies removed by the FDA from the EUA process for the other gene therapy products? This removal is unexplained and points directly at the Trumpian Operation Warp Speed (TOWS). He remarks on the absence of Ethics Boards, the absence of Data Safety Monitoring Boards and the absence of Critical Events Committees for the other gene therapy products. The system developed in the US to record adverse events is known as the Vaccine Adverse Event Reporting System (VAERS) and co-administered by the US Centers for Disease Control and Prevention (CDC) and the FDA. The system developed in the US to regulate and monitor the exchange of labour for money is known as the Occupational Safety and Health Administration (OSHA) and administered by the US Department of Labour. The OSHA has waived the requirement for employers to report any adverse events that stem from the individual employers' own power to require jabs of employees. The liability for these gene therapy products (some of which are scientifically unknown by virtue of the TOWS) would seem to accrue to the Federal government. From government of, by and for the people it is difficult not to see the degeneracy to government against the labouring and lower classes.

Youngblood next mentions the astonishing climb in numbers of VAERS incidents. The pre-covid19 average was on the order of 17,000 incidents per year. Over the 10 months to date of 2021 VAERS has seen an increase to 752,000. Clearly, the system has registered a monumentally alarming increase in health problems. In other words, public health has deteriorated in the US as a result of the gene therapy products that are shovelled down the throats of the masses.

From 4:06-4:51, Youngblood details perhaps the most frightening conclusion of all: the VAERS statistic on "elapsed time of death after the administration of the gene therapy jab" spikes during the 48 hours post-administration, yet apparently the CDC has chosen by fiat to ignore this statistic and thereby to strangle the tar baby. Whereas the death count within 28 days of a positive covid19 test is tallied as the result of covid19 even if the cement truck ran you over. Can you say unbalanced?

From 4:51-5:24 Youngblood details the 2020 malfeasance of the FDA: while it had been told scientifically in Pfizer's EUA application of the severe side effects of the Pfizer product it failed to communicate to the medical professionals who administer the gene therapy product the potential side effects of the gene therapy product.

Youngblood next from 5:24-5:54 makes perhaps his weakest point.

From 5:54-6:21 he statistically and scientifically questions based on the CDC's own data the "unvaccinated are putting at risk the vaccinated" narrative. The CDC's own facts destroy its narrative and are nonsensical and counterfactual.

From 6:21-7:11 he remarks that the virus has evolved such that it is now subject to a 50% reduced jab efficacy, and notes that the original potency of the jab appears to wane after six to eight months.

Youngblood concludes with the bold statement that there is no medical justification for covid19 jab mandates by government or employers.

Loading comments...